Merida Biosciences
Latest round
- Series A
Last raised
- Apr 2025
Total raised
- $141M
Investors
- 5
About Merida Biosciences
Founded in 2022 and based in Cambridge, US, Merida Biosciences specializes in precision therapies for antibody-driven diseases.Merida Biosciences specializes in the development of innovative therapies targeting autoimmune and allergic disorders through its proprietary platform. The company’s core product offerings focus on precision therapies designed to eliminate pathogenic drivers of antibody-driven diseases, providing targeted intervention that addresses the root causes of conditions rather than merely alleviating symptoms. These therapies aim to improve patient outcomes by delivering greater efficacy with a reduced risk of serious side effects. The company is actively engaging with healthcare providers and biotechnology partners across North America and Europe, targeting markets where the prevalence of autoimmune diseases is significant.Merida Biosciences generates revenue through a combination of partnerships and direct sales of its therapeutic products, emphasizing collaborative relationships with healthcare institutions and biopharmaceutical companies. The transaction structure typically involves establishing partnerships that may include milestone-based payments and royalties on sales, particularly as products progress through clinical development and receive regulatory approval. The company’s flagship products are positioned for significant market entry following successful clinical trials, with pricing strategies aligned to competitive market standards within the biotechnology sector.In April 2025, Merida Biosciences, Inc. Specific upcoming products are currently underway, with strategic plans for entering new markets across North America and Europe.
Who invested in Merida Biosciences
5 investors across 2 rounds
See all investors in Merida Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Merida Biosciences
Who invested in Merida Biosciences?
Merida Biosciences has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Merida Biosciences raised?
Merida Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Merida Biosciences last raise money?
Merida Biosciences's most recent round on record is a Series A, in Apr 2025.
What does Merida Biosciences do?
Founded in 2022 and based in Cambridge, US, Merida Biosciences specializes in precision therapies for antibody-driven diseases.
Where is Merida Biosciences headquartered?
Merida Biosciences is headquartered in Cambridge, US.
Which VCs invest in companies like Merida Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Merida Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Merida Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.